Cargando…
Cardiomyocyte Death and Genome-Edited Stem Cell Therapy for Ischemic Heart Disease
Massive death of cardiomyocytes is a major feature of cardiovascular diseases. Since the regenerative capacity of cardiomyocytes is limited, the regulation of their death has been receiving great attention. The cell death of cardiomyocytes is a complex mechanism that has not yet been clarified, and...
Autores principales: | Cho, Hyun-Min, Cho, Je-Yoel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316208/ https://www.ncbi.nlm.nih.gov/pubmed/33492627 http://dx.doi.org/10.1007/s12015-020-10096-5 |
Ejemplares similares
-
Transplantation of hMSCs Genome Edited with LEF1 Improves Cardio-Protective Effects in Myocardial Infarction
por: Cho, Hyun-Min, et al.
Publicado: (2020) -
Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis
por: Jeong, Hyunsuk, et al.
Publicado: (2018) -
NQO1 is Required for β-Lapachone-Mediated Downregulation of Breast-Cancer Stem-Cell Activity
por: Kim, Dong Wook, et al.
Publicado: (2018) -
Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart Disease
por: Zhu, Kai, et al.
Publicado: (2016) -
Inducible HGF-secreting Human Umbilical Cord Blood-derived MSCs Produced via TALEN-mediated Genome Editing Promoted Angiogenesis
por: Chang, Hyun-Kyung, et al.
Publicado: (2016)